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Abstract
Preosteoblasts are precursor cells that are committed to the osteoblast lineage. Differentia-
tion of these cells to mature osteoblasts is regulated by the extracellular factors and environ-
mental cues. Recent studies have implicated mTOR signaling in the regulation of
osteoblast differentiation. However, mTOR exists in two distinct protein complexes
(mTORC1 and mTORC2), and the specific role of mTORC1 in regulating the progression of
preosteoblasts to mature osteoblastis still unclear. In this study, we first deleted Raptor, a
unique and essential component of mTORC1, in primary calvarial cells. Deletion of Raptor
resulted in loss of mTORC1 but an increase in mTORC2 signaling without overtly affecting
autophagy. Under the osteogenic culture condition, Raptor-deficient cells exhibited a de-
crease in matrix synthesis and mineralization. qPCR analyses revealed that deletion of
Raptor reduced the expression of late-stage markers for osteoblast differentiation (Bglap,
Ibsp, and Col1a), while slightly increasing early osteoblast markers (Runx2, Sp7, and Alpl).
Consistent with the findings in vitro, genetic ablation of Raptor in osterix-expressing cells
led to osteopenia in mice. Together, our findings have identified a specific role for mTORC1
in the transition from preosteoblasts to mature osteoblasts.
Introduction
Preosteoblasts are a heterogeneous population of progenitor cells that are committed to the os-
teoblast lineage [1, 2]. Preosteoblasts are derived from multi potent mesenchymal progenitor
cells (MPs), and can further differentiate along the osteoblast lineage into mature osteoblasts
(the major bone-forming cells) in response to osteogenic signals. The identities of preosteo-
blasts are still not fully understood, but they initially express the transcription factor Runx2,
and then both Runx2 and Sp7 (Osterix) [2]. The process of osteoblast differentiation, including
transitioning of preosteoblasts into mature osteoblasts, is tightly regulated by extracellular fac-
tors and environmental cues either positively or negatively [2].
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The mechanistic target of rapamycin (mTOR) pathway is an evolutionally conserved nutri-
ent-sensing pathway that controls many major cellular processes [3]. mTOR is a serine/threo-
nine kinase, which exists in two different complexes (mTORC1 and mTORC2). These two
complexes can be distinguished by their specific and essential components, such as Raptor for
mTORC1 and Rictor for mTORC2. Activated by upstream signals, mTORC1 and mTORC2
control different downstream effectors and cellular processes [4]. Genetic deletion of raptor or
rictor in the early embryonic mesenchyme in the mouse has revealed important roles for-
mTORC1 and mTORC2 in skeletal development. mTORC1 is crucial for the regulation of
chondrocyte size, hypertrophy and matrix production [5], whereasmTORC2 enhances bone
formation [6]. These studies, however, did not address the role of mTOR specifically in
preosteoblasts.
Recently, the mTOR pathway has been also implicated in controlling MPs fate and osteo-
blast differentiation. Studies using mTOR inhibitor rapamycin or mTOR gene ablation showed
that mTOR signaling could exert both stimulatory [7, 8, 9, 10, 11] and inhibitory [12, 13, 14,
15] effects on osteoblast differentiation. These conflicting results may reflect stage-specific
roles of mTOR within the osteoblast lineage. Moreover, since prolonged treatment with rapa-
mycinor gene deletion of mTOR inhibits both mTORC1 and mTORC2pathways [3], the spe-
cific role of mTORC1 in osteoblast differentiation remains unclear.
In the current study, by using the Cre/LoxP technology to delete Raptor in primary cultures
of calvarial preosteoblasts, orin osterix-expressing cells in mice, we demonstrate a critical role
formTORC1 in the transition of preosteoblasts to mature osteoblasts.
Materials and Methods
Mouse strains
Osx-Cre and Raptorf/f mouse lines were previously reported [16, 17] and were obtained from
Jackson Laboratory (Bar Harbor, ME). This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory Animals of the National In-
stitutes of Health. The protocol in this study was approved by Animal Studies Committee at
Washington University. All efforts were made to minimize animal suffering.
X-ray radiography and μCT
Six week-old mice were euthanized by trained personnel using carbon dioxide, and then limbs
were collected for X-ray and μCTanalyses. X-ray radiography was conducted on hind limbs
with a Faxitron X-ray system at 25 kv for 20 seconds. μCT analyses were performed with
Scanco μCT 40 (Scanco Medical AG) according to ASBMR guidelines [18]. 100 μCT slices (1.6
mm total) immediately below the growth plate of the tibias were used for 3D reconstruction
and quantification of trabecular bone parameters.
Primary calvarial cell isolation and adenovirus infection
To isolate calvarial cells, newborn Raptorf/f pups were euthanized by decapitation with sharp
scissors. Subsequently, the frontal and parietal bones (FPB) were dissected, rinsed with PBS,
and then subjected to five serial digestions with 1.8 mg/ml collagenase (Sigma). The first diges-
tion was discarded and digestions two to five were pooled and then filtered through a 70 μm
cell strainer. Collected cells were seeded in 12-well plate sat 1.5×105 cells/well. After overnight
culture, cells were infected with adenovirus expressing either green fluorescence protein (Ad-
GFP) or Cre(Ad-CRE) at a multiplicity of infection of 50. At 72 h after adenoviral infection,
cells were either harvested for protein analysis or induced for osteoblast differentiation by
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osteogenic medium (αMEMmedia with 10% FBS, 10mM β-glycerol phosphate and 50μg/ml
ascorbic acid). Osteogenic medium was changed every other day.
Mouse bone marrow stromal cell (BMSC) cultures and osteogenic
differentiation
Six week-old RapCKO or control mice were euthanized by carbon dioxide method prior to iso-
lation of BMSCs. Isolation, culture, and osteogenic differentiation of BMSCs were performed
as previously described [6].
Alkaline phosphatase (AP) staining and Von Kossa Staining
For AP staining, cells were fixed with 3.7% formaldehyde, rinsed with PBS, and then incubated
with a reaction mixture (0.1 mg/ml naphthol AS-MX phosphate,0.6 mg/ml Fast blue BB
Salt,0.5% N, N-demethylformamide, 2 mMMgCl2, and 0.1 M Tris/HCl) at room temperature
for 20 minutes. For Von Kossa staining, cells were fixed in cold methanol, rinsed with distilled
water, and then incubated with 5% silver nitrate solution under bright light for 30 minutes. Ex-
cess stain was washed off with double distilled water.
Quantitative real-time PCR (qPCR) andWestern blot
Total RNA was extracted from cells using the QiagenRN easy kit following the manufacturer’s
instructions. One microgram of isolated RNA was reverse transcribed to cDNA using the
iScriptcDNA synthesis kit (Bio-Rad) according to the manufacturer’s protocols. qPCR was
conducted with SYBR-Green Supermix (Bio-Rad). Relative gene expression was determined by
first normalization to β-actin, and then normalization to control samples.
Western blot analyses were performed as previously described [5]. Antibodies for S6,pS6
(S240/244), Akt, pAKT (S473), Raptor, Rictor, LC3B, and β-actin were all purchased from Cell
Signaling Technology. All antibodies were used at 1:1000.
Enzyme-Linked Immunosor bent Assay (ELISA) for P1NP
P1NP levels in the culture medium of calvarial cells were determined by Enzyme-Linked
Immunosor bent Assay (ELISA) using the Rat/Mouse P1NP EIA kit (Immunodiagnostic Sys-
tems, Ltd.) according to the manufacturer’s recommendation.
Statistics
All quantitative data are presented as mean ± STDEV with a minimum of three independent
samples. Statistical significance is determined by two-tailed Student’s t-test. P-value less than
0.05 is considered statistically significant.
Results
Deletion of Raptor in preosteoblasts disruptedmTORC1 but activated
mTORC2 signaling
To determine the specific role of mTORC1 in osteoblast differentiation, we isolated primary
osteoblast precursors from the calvarium of neonatal Raptorf/f mouse, and infected these cells
with adenoviruses expressing GFP (Ad-GFP) or Crerecombinase (Ad-Cre). Western blot anal-
ysis showed that Raptor protein was efficiently deleted 3 days after adenovirus infections (Fig
1). As expected, Rictor protein was intact in Ad-Cre infected cells (Fig 1). We then examined
the effects of Raptor deletion on mTORC1 and mTORC2 activity. Western blot showed that
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phosphorylation of S6 at sites of S240/244 (a readout of mTORC1 activity) was dramatically re-
duced, while phosphorylation of Akt at S473 (a specific target of the mTORC2 complex) was
significantly increased (Fig 1). These data indicated that deletion of Raptor led to impaired
mTORC1 activity and enhanced mTORC2 activity. In addition, mTORC1 signaling is known
to suppress autophagy in many cell types [3]. Because autophagy has been shown to regulate
osteoblast differentiation and activity [19, 20], we asked whether deletion of Raptor in preos-
teoblast cells activated autophagy. To this end, we analyzed LC3B isoforms (LC3B-I and
LC3B-II) by Western blot, since the conversion of LC3-I to the lower migrating form, LC3-II,
Fig 1. Deletion ofRaptor in preosteoblasts disrupted mTORC1 but activatedmTORC2 signaling.
Western blot analyses of primary calvarial cells isolated from Raptorf/fneonates and infected with
adenoviruses expressing GFP (Ad-GFP) or Cre (Ad-Cre) for 3 days.
doi:10.1371/journal.pone.0130627.g001
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is commonly used as an indicator of autophagy [21]. There was no difference in either LC3B-I
or LC3B-II between WT and Raptor-deleted cells, indicating that disruption of Raptor/
mTORC1 does not activate autophagy in the preosteoblasts.
Deletion of Raptor in preosteoblasts reduced matrix synthesis and
mineralization
We next assessed the capability of Raptor-deficient cells to differentiate into mature osteoblasts
capable of forming a mineralized extracellular matrix. To this end, we treated Ad-GFP- or Ad-
Cre-infected Raptorf/f calvarial cells with the osteogenic medium containing 10mM β-glycerol
phosphate and 50μg/ml ascorbic acid to induce osteoblast differentiation and matrix minerali-
zation. Von kossa staining detected mineralized bone nodules in control cells after 14 days of
osteogenic inductions (Fig 2). In contrast, mineralized bone nodulesin Ad-Cre-infected cells
were dramatically reduced (Fig 2). To assess bone matrix production, we examined the level of
the amino terminal propeptide of type I procollagen(P1NP)in the culture medium, and found
that the raptor-deficient cells produced significantly less P1NP (Fig 2). Alkaline phosphatase is
known to regulate matrix mineralization. Therefore, in parallel experiments, we performed al-
kaline phosphatase staining. Surprisingly, Raptor-deficient cells exhibited slightly higher levels
of alkaline phosphatase activity after7 days of the osteogenic induction (Fig 2). Therefore, dele-
tion of raptor impaired matrix production and mineralization without reducing alkaline
phosphatase activity.
Fig 2. Deletion ofRaptor in preosteoblasts reducedmatrix synthesis andmineralization. (A-B) Alkaline
phosphatase (AP) staining of wildtype (Ad-GFP)(A) versus Raptor-deficient (Ad-Cre)(B) calvarial cells after 7
days (D7) of osteogenic differentiation. (C-F)Von Kossastaining of wildtype (Ad-GFP)(C, E) versus Raptor-
deficient (Ad-Cre)(D, F) calvarial cells after 14 days (D14) of osteogenic differentiation. Panels C-D showed
lower magnification images; Panels E-F showed higher magnification images. (G) Quantification of bone
nodules detected by Von Kossa staining. n = 3; *:P<0.05. (H) ELISA analysis of P1NP levels in wildtype (Ad-
GFP) versus Raptor-deficient (Ad-Cre) calvarial cells after 14 days (D14) of osteogenic differentiation. n = 3;
*:P<0.05.
doi:10.1371/journal.pone.0130627.g002
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Raptor/mTORC1 pathway is dispensable for the early stages of
osteoblast differentiation
To determine whether the reduced bone nodules in Raptor-deficient cells was due to a defect in
osteoblastogenesis, we first performed qPCR to analyze the expression of early markers for os-
teoblast differentiation (Alpl, Runx2, and Sp7). Consistent with the result from alkaline phos-
phatase staining, mRNA level of Alpl, a commonly used marker for early osteoblasts [22], was
slightly but significantly increased in Raptor-deficient cells (Fig 3). Similarly, Runx2and Sp7,
both transcriptional factors essential for osteoblast differentiation were higher in Raptor-defi-
cient cells (Fig 3). In summary, these data indicate that Raptor is dispensable for the early steps
of osteoblast differentiation.
Raptor/mTORC1 pathway promotes the late stages of osteoblast
differentiation
Increased expression of early-stage markers for osteoblast differentiation in Raptor-deficient
cells could be due to either enhanced osteoblastogenesis at all stages or arrest of differentiation
at early stages. To distinguish these two possibilities, we examined expression of late stage
markers for osteoblast differentiation, including Bglap, Ibsp, and Col1a. qPCR analysis revealed
that both Bglap (encoding osteocalcin), a definitive marker for mature osteoblast, and Ibsp
were markedly reduced whereas Col1a was mildly decreased in the mutant cells (Fig 4). Thus,
raptor deletion caused a defect in the late stage of osteoblast differentiation.
Fig 3. Raptor/mTORC1 pathway is dispensable for the early stages of osteoblast differentiation. qPCR
analyses of early osteoblast markers in wildtype (Ad-GFP) versus Raptor-deficient (Ad-Cre) calvarial cells
after 7 days (D7) of osteogenic differentiation. *: P<0.05, n = 3.
doi:10.1371/journal.pone.0130627.g003
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Reduced trabecular bone mass inOsx-cre; Raptorf/fmice
The data so far has demonstrated that mTORC1 plays a role in the formation of mature osteo-
blasts in vitro. To assess the role of mTORC1 in vivo, we generated Osx-cre; Raptorf/f condition-
al knockout mice to specifically disrupt mTORC1 in Osx-expressing cells. X-ray radiography
indicated that mutant mice have slightly shorter bones compared to Osx-Cremice (Control)
(Fig 5). μCT analyses of the trabecular bone in the proximal tibias showed a significant reduc-
tion in bone mass (BV/TV) in 6 week-old Osx-cre; Raptorf/f mice when compared to control
mice (Fig 5). The decrease in bone mass was due to both reduced trabecular number and tra-
becular thickness while accompanied by a significant increase in trabecular spacing (Fig 5).
Our data suggested that Raptor/mTORC1 in Osx-expressing cells is important for promoting
trabecular bone mass in mice.
To further support a specific role of mTORC1 in osteoblast differentiation, we isolated bone
marrow stromal cells from 6 week-old Osx-cre; Raptorf/f and control mice, and then treated
them with osteogenic medium to induce osteoblast differentiation. Von Kossa staining detected
abundant matrix mineralization in control cells after 14 days of osteognic induction, whereas
BMSCs from Osx-cre; Raptorf/f mice largely failed to undergo mineralization, as evidenced by
the lack of Von Kossa staining (Fig 6). In contrast, AP staining revealed that RapCKO BMSCs
exhibited higher levels of alkaline phosphatase staining after 7 days of osteogenic induction
(Fig 6). Collectively, these data suggested that reduced trabecular bone mass in Osx-cre; Rap-
torf/f mice is at least partially due to a defect in late stages of osteoblast differentiation.
Discussion
Primary calvarial cells are commonly used as a cell culture system for studying osteoblast dif-
ferentiation. Primary calvarial cells isolated from neonatal mice are mostly progenitor cells that
Fig 4. Raptor/mTORC1 pathway promotes the late stages of osteoblast differentiation. qPCR analyses
of late osteoblast markers in wildtype (Ad-GFP) versus Raptor-deficient (Ad-Cre) calvarial cells after 7 days
(D7) of osteogenic differentiation. *: P<0.05, n = 3.
doi:10.1371/journal.pone.0130627.g004
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Fig 5. Osx-cre; Raptorf/fmice exhibited reduced trabecular bonemass. (A-B) Representative X-ray
images of hind limbs of 6 week-oldOsx-Cre (Ctrl) (A) orOsx-Cre; Raptorf/f(RapCKO) mice. (B). (C-D) μCT
three-dimensional reconstruction of metaphyseal trabecular bone of the tibia from 6 week-oldOsx-Cre (Ctrl)
(C) orOsx-Cre; Raptorf/f (RapCKO) littermate mice(D). (E-H) μCT quantification of proximal metaphyseal
trabecular bone parameters. BV: bone volume; TV: total volume; Tb. N*: trabecular number; Tb. Th*:
trabecular thickness; Tb. Sp*: trabecular spacing. Quantification was performed on 100 of 16 μm slices
immediately below the growth plate. Ctrl: n = 5; RapCKO: n = 4; *:P<0.05.
doi:10.1371/journal.pone.0130627.g005
Fig 6. Bonemarrow stromal cells isolated fromOsx-cre; Raptorf/fmice exhibited reducedmatrix
synthesis andmineralization. (A-B) Alkaline phosphatase (AP) staining of bone marrow stromal cells
isolated fromOsx-Cre (Ctrl) (A) orOsx-Cre; Raptorf/f(RapCKO) mice after 7 days (D7) of osteogenic
differentiation. (C-D) Von Kossa staining of bone marrow stromal cells isolated fromOsx-Cre (Ctrl) (A) or
Osx-Cre; Raptorf/f(RapCKO) mice after 14 days (D14) of osteogenic differentiation.
doi:10.1371/journal.pone.0130627.g006
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are committed to the osteoblast lineage [1, 23]. By deleting Raptor in primary calvarial cells,
our study revealed a critical role of mTORC1 in promoting osteoblast differentiation. In line
with this, conditionally ablating Raptor in osterix-expressing cells in mice led to reduced tra-
becular bone mass. This suggested a role of mTORC1 in osteoblast differentiation in vivo.
However, it should be mentioned that Osx-cre targets multiple cell types besides osteoblast
lineage in postnatal mice [24]. Therefore, it still needs to be determined whether reduced
trabecular bone mass in Osx-cre; Raptorf/f mice was caused solely by impaired osteoblast
differentiation.
mTOR has been shown to be involved in regulating MPs lineage selection and osteoblast
differentiation. However, mTOR participates in two different complexes, mTORC1 and
mTORC2. Although a number of studies have demonstrated the pro-osteogenic role of
mTORC2 in MPs [6, 25, 26, 27], the specific role played by mTORC1 in osteoblast differentia-
tion is still controversial. By genetically deleting Raptor in MPs, a recent study showed that loss
of Raptor promotes osteogenesis and inhibits adipogenesis [26]. Here, we showed that
mTORC1 is important for late stages of osteoblast differentiation. The opposite results from
these two studies may indicate that mTORC1 plays opposite roles in different stages of osteo-
blast differentiation. Future studies are warranted to test this possibility.
Raptor-deficient calvarial cells exhibit eda defect in osteoblast differentiation. Whether
mTORC1 directly regulates osteoblast activity cannot be determined in the present study, asos-
teoblast activity is secondarily affected by impaired osteoblast differentiation. To address direct
effects of mTORC1 on osteoblast activity, further studies should be performed on mature
osteoblast.
Although mTORC1 is clearly involved in osteoblast differentiation, it is still unclear which
downstream effector(s) mediate the function of mTORC1. Eukaryotic translation initiation
factor 4E (eIF4E)-binding protein 1 (4E-BP1) and S6 kinase 1 (S6K1) are two major targets of
mTORC1 pathway, both of which regulate protein synthesis [4]. It will be interesting to deter-
mine whether 4E-BP1 or S6K1 or both is the downstream mediator of mTORC1 in osteoblast
differentiation.
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